Skip to main content
Premium Trial:

Request an Annual Quote

Coda Genomics, UC Irvine Win $583K NIAID Grant to Develop Gene Assembly, Protein Expression Tech

NEW YORK, Sept. 1 (GenomeWeb News) - Coda Genomics and the University of California, Irvine, have won an STTR grant for $582,993 from the National Institute of Allergy and Infectious Diseases to develop their gene assembly and protein expression technology further, the Irvine, Calif.-based company said today.


Coda, founded last year, has been commercializing DNA assembly and protein expression-optimization technology developed by Richard Lathrop and Wesley Hatfield at the Universityof California, Irvine. In addition to DNA assembly thermodynamics, Coda optimizes codon usage preferences and patented codon pairwise combinations that control translational kinetics to generate higher levels of protein expression.


The NIAID grant will allow the company to further develop the technology for large mutational studies.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.